ClinicalTrials.gov
public full text
Public Domain
Intranasal Esketamine to Maintain the Antidepressant Response to IV Racemic Ketamine
This study aims to assess the efficacy and safety of intranasal esketamine as maintenance antidepressant therapy in patients who have demonstrated clinical improvement with off-label intravenous racemic ketamine for treatment-resistant depression.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Tolerance Assesment of the Usage of an Analgesic Dose of Esketamine for Treatment of Moderate to Intense Pain in an Emergency Departement#1384907
- Effects of Intranasal Ketamine on Depression and Anxiety in Palliative Care Cancer Patients#895014
- Sex differences in placebo and antidepressant response to intranasal esketamine for treatment-resistant depression#311527
- An Exploratory Study of Esketamine in Patients After Thoracoscopic Surgery#911921
- A Study to Evaluate the Safety and Efficacy of Intranasal Esketamine in Treatment-resistant Depression#844985
Record · ID 1410054
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive